Your session is about to expire
← Back to Search
Intervention Group for Foot Ulcer
Study Summary
This trial is collecting patient outcome data on the KerecisTM Omega3 Wound, a commercially available product that is derived from minimal processing of Atlantic cod fish skin. The primary endpoint is the percentage of index ulcers healed at 12 weeks.
- Diabetic Foot Ulcers
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the recruitment process for this investigation currently open to participants?
"The clinicaltrials.gov listing reveals that this study, which was posted on July 31st 2019 and last updated on July 4th 2022 is not currently looking for participants. However, there are 137 other medical trials actively enrolling patients at the moment."
How widely is this research endeavor being conducted?
"Drs. Christopher Winters, Brock Liden and Allen Raphael are administering the trial out of their respective offices in Carmel, Circleville and Smyrna respectively alongside 5 ancillary medical centres."
Share this study with friends
Copy Link
Messenger